Glenmark Pharma Shares Fall Over 5% After Nirmas Acquisition News

Glenmark Pharma share price declined over 5% in early trade on September 22 after the company announced that it would sell a 75% stake in its subsidiary Glenmark Life Sciences to Nirma for Rs 615 per share. Nirma will also make a mandatory open offer to all public shareholders of Glenmark Life Sciences for an additional 17.15% stake at Rs 631 a share.